Committees
Hundreds of volunteer members serve on ACMG committees, contributing their expertise to advance the College’s mission. Each committee’s full roster is available via the “View Full Roster” link.
ACMG Board of Directors
President: Mira B. Irons, MD, FACMG
Log in to view email
ACMG Foundation Board of Directors
President: Brynn Levy, MSc(Med), PhD, FACMG
Log in to view email
Advocacy and Government Affairs Committee
Chair: David H. Viskochil, MD, PhD, FACMG
Log in to view email
Community, Outreach and Engagement Committee
Chair: Fabiola Quintero-Rivera, MD, FACMG
Log in to view email
Continuing Certification Program Committee
Chair: Ayuko Iverson, MD, FACMG
Log in to view email
Economics of Genetic Services Committee
Chair: Nancy B. Spinner, PhD, FACMG
Log in to view email
Education and Professional Development Committee
Chair: Lauren B. Carter, MD, FACMG
Log in to view email
Ethical, Legal, and Social Issues
Chair: Dena Matalon, MD, FACMG
Log in to view email
International Outreach and Engagement
Chair: Marwan K. Tayeh, PhD, MS, FACMG
Log in to view email
Laboratory Quality Assurance Committee
Chair: Honey V. Reddi, PhD, FACMG
Log in to view email
Membership Committee
Chair: Mauro Longoni, MD, FACMG
Log in to view email
Professional Practice and Guidelines Committee
Chair: Aya Abu-El-Haija, MD, MPH, FACMG
Log in to view email
Program Committee for Annual Meeting
Chair: Nathan D. Kopp, PhD, FACMG
Log in to view email
Therapeutics Committee
Chair: Loren D. Pena, MD, PhD, FACMG
Log in to view email
Topic Selection Committee
Chair: Michael F. Murray, MD, FACMG
Log in to view email
Workforce Development and Optimization
Chair: Donald Basel, MD, FACMG
Log in to view email
Special Interest Groups
Adult Disease
Theodore G. Drivas, MD, PhD, FACMG (Co-Chair)
The objectives and goals of the Adult Disease Special Interest Group are: (1) To foster awareness and understanding among stakeholders (consumers, health professionals, insurers, policy makers, etc.) of the role of clinical genetics and genomics in adult medicine; (2) To support and provide evaluation of educational programs that address clinical genetics issues for adults; (3) To promote the use of and support the development of guidelines for the recognition, detection and management of adult genetic disorders; (4) To promote research evaluating the clinical utility and outcomes of genetic intervention (evaluation/consultation) in the detection and management of adult genetic disorders and disease.
Digital Health
David Flannery, MD, FACMG (Chair)
The goal of this SIG is to bring together the digital health and medical genetics communities to advance ACMG’s mission and identify how application of new technologies will facilitate the incorporation of genomic medicine into health care to achieve the ultimate goal of increased access to personalized medicine for all.
Medical Directors
Fuki M. Hisama, MD, FACMG (Co-Chair)
This special interest group provides a discussion forum for physicians in a leadership position for a clinical genetics service to discuss topics related to clinical service. Medical directors face challenges when setting expectations for clinical productivity, or when asking for additional resources. This SIG offers an avenue for leaders of clinical programs to share experiences, best practices and discuss topics such as faculty productivity expectations and workflow.
Pharmacogenomics
Annette Taylor, PhD, MS, FACMG (Chair)
The goal of this SIG is to bring together the pharmacogenomics and medical genetics communities to advance ACMG’s mission and improve implementation of pharmacogenomic testing throughout other medical specialties.
Public Health Genetics
Monica Wojcik, MD, FACMG (Chair)
The mission of the Public Health Interest Group is to provide a forum for (1) Information sharing regarding programs in public health genetics and newborn screening; ethical, legal, and social issues in public health genetics and newborn screening; translational genetics activities; and scientific and clinical advances in public health genetics and newborn screening; (2) Development of policies and papers related to public health genetics and newborn screening to be shared, as appropriate, with ACMG committees and/or the Board of Directors.
Quality Improvement
Amy Kritzer, MD, FACMG (Co-Chair), Stephanie Santoro, MD (Co-Chair)
Quality improvement (QI) in clinical medicine is increasingly recognized as a robust approach to rapidly correct problems and improve the care of patients. QI is an iterative process that continues to modify the system to continuously improve outcomes, and insure that the improved outcome persists. QI projects of the ACMG SIG include: Metabolic Disease data collection and follow-up; Family History; Evaluation of Developmental Delay and Mental Retardation; Neurofibromatosis Type 1; Evidence-based interventions for Autism; Genetics Pedigree Project; Patient Satisfaction Survey Standardization.